Home
NICE Guidance
Conditions and diseases
Kidney conditions
Chronic kidney disease
Chronic kidney disease
Savings and productivity
Register as a stakeholder
Show sections
Do not do
Supplements of vitamin C should not be prescribed as adjuvants specifically for the treatment of anaemia of chronic kidney disease (CKD).
February 2011
In people with anaemia of chronic kidney disease (CKD), androgens should not be used to treat the anaemia.
February 2011
The correction to normal levels of haemoglobin (Hb) with erythropoiesis-stimulating agents (ESAs) should not routinely be recommended in people with anaemia of chronic kidney disease (CKD).
February 2011
Supplements of folic acid should not be prescribed as adjuvants specifically for the treatment of anaemia of chronic kidney disease (CKD).
February 2011
Supplements of carnitine should not be prescribed as adjuvants specifically for the treatment of anaemia of chronic kidney disease (CKD).
February 2011
Do not diagnose CKD in people with: an eGFRcreatinine of 45 59 ml/min/1.73 m2 and an eGFRcystatinC of more than 60 ml/min/1.73 m2 and no other marker of kidney disease.
July 2014
Do not use reagent strips to identify proteinuria unless they are capable of specifically measuring albumin at low concentrations and expressing the result as an ACR.
July 2014
Do not use urine microscopy to confirm a reagent strip positive result when testing for the presence of haematuria.
July 2014
Do not use age, gender or ethnicity as risk markers to test people for CKD.
July 2014
In the absence of metabolic syndrome, diabetes or Hypertension, do not use obesity alone as a risk marker to test people for CKD.
July 2014
Full List
Guidance
Resources
Savings and productivity
Local practice